Zero Gravity Solutions

Plants have the natural ability to protect themselves from the harms of stress and disease. Zero Gravity’s pioneering technology unlocks this ability for the benefit of the $3.5T agriculture industry. With 2 products and 5 distribution deals, Zero Gravity is at the tipping point of rapid growth.

Claim My Business
Security Type
Common Stock
Min Investment
Boca Raton, FL
Offering Date
March 19, 2024
Expected Close Date
April 29, 2024
Target Raise
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

In the face of increasing droughts and extreme weather caused by global climate change, the world needs to find a way to sustainably feed a world population that is forecast to grow by an additional 2 billion people over the next 30 years.Our scientific discoveries are the basis for a rapidly expanding intellectual property portfolio based on multiple organic priming elicitors, how they work in plants, and their product applications.Zero Gravity Solutions is on a mission to unlock the natural power of plants to increase agricultural yields while limiting the use of potentially harmful synthetic chemicals. By “priming” the plant’s natural physiology, our company’s technology has been shown to significantly improve crop yields, manage disease, and mitigate stress. After 7+ years of research, 65+ field trials across 35+ crop varieties, Zero Gravity has two products with sales from major distributors including Rite-Aid. Over the next two years, we plan additional product launches and further expansion into larger product sectors.

Management Team / Advisory Board Bios

John McLean
John is an agriculture industry executive with 40 years of diverse industry experience including as COO of Monsanto Growth Ventures and as President of Intrexon Crop Protection.

Ravi Pottathil
Ravi is an entrepreneur with a 40-year history spanning industry & academia, covering biochemistry, molecular biology, mammalian genetics, medical virology, tumor biology, and diagnostics.

Kathy Conway

Head of Operations

Agbiotech leader with 35 years of experience in strategic operations, driving companies the next stage of growth from product development through commercialization

Matt Cleaver
Head of Business Development
Business development and strategy leader with over a decade of experience driving growth and performance across multiple businesses in the food and agriculture industry.

Rik Miller
Commercial Advisor
Rik has 40+ years of experience in production agriculture including as President of Crop Protection at Dupont and senior leadership positions in sales, marketing, portfolio management, and business operations.

Brad Shurdut
Regulatory Advisor
Brad is an attorney and senior life sciences, biotechnology, and ag industry executive with 30+ years of experience in government affairs, regulatory affairs, public policy, environmental health & safety, and risk assessment.
Amount Raised : $118,149
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter